People with atopic dermatitis are taking to social media to share dramatic images of red, cracked, peeling skin that they blame on overuse of steroid creams. But their dermatologists may not agree.

These steroids come in various strengths, with lower-potency options available over the counter and higher-potency creams as a prescription. But they're not meant to be a long-term solution for the ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Over the past ...

Pimecrolimus, a calcineurin inhibitor immunosuppressant, was found to provide the most improvement with regard to gaining AD control. Pimecrolimus, tacrolimus, and moderate potency topical ...

Lawrence Eichenfield, MD, FAAD, from Rady Children's Hospital and UC San Diego School of Medicine, highlighted the importance of shared decision-making in atopic dermatitis treatment, emphasizing ...

Please provide your email address to receive an email when new articles are posted on . Combination lebrikizumab and topical corticosteroids outperformed topical corticosteroids alone in the treatment ...

The most reported symptoms were pruritus, sleep disturbance, and signs of anxiety and depression. HealthDay News — Self-reported manifestations of topical steroid withdrawal (TSW) in atopic dermatitis ...

Experts discuss the impact of severe eczema on children’s daily lives and the role of newer non-steroidal topical therapies in effectively managing mild to moderate cases, delaying the need for costly ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Please provide your email address to receive an email when new articles are posted on . Zabalafin is a novel, first-in-class, multi-target therapeutic natural drug. 40% of Zabalafin-treated patients ...